← Back to Clinical Trials
Recruiting NCT07011940

NCT07011940 Walk With Me (WWM) for Perinatal Grief

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07011940
Status Recruiting
Phase
Sponsor Oregon Research Behavioral Intervention Strategies, Inc.
Condition Grief
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2025-07-13
Primary Completion 2027-08-01

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Along With MePeer Guide

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2025-07-13 with a primary completion date of 2027-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if the Along With Me web-based intervention works to decrease posttraumatic stress symptoms and suicidal ideation among bereaved parents following pregnancy and early infant loss. It will also learn whether peer guides provide additional improvements on these outcomes. The main questions it aims to answer are: • Do people who receive Along With Me or Along With Me plus a Peer Guide compared to services as usual have lower posttraumatic stress symptoms and suicidal ideation than those who do not receive the intervention? Researchers will compare Along With Me and Along With Me plus a Peer Guide to services as usual (referrals made in the hospital setting) to see if Along With Me works to prevent and address posttraumatic stress symptoms and suicidal ideation. Participants will: * Receive access to a mobile app with approximately 10 therapeutic modules about how to manage grief and other symptoms. * Receive check-ins with a Peer Guide (in the Peer Guide condition only)

Eligibility Criteria

Inclusion Criteria: * Within the first month of pregnancy or early infant loss * Reside in the United State * Speak and read either English or Spanish at a 6th grade reading level * 15 or older Exclusion Criteria: * Not pregnant or has not experienced an early infant loss * Does not reside in the United State * Does not speak and read either English or Spanish at a 6th grade reading level * 14 or younger

Contact & Investigator

Central Contact

David R Smith, PhD

✉ david.smith@influentsin.com

📞 541-484-2123

Principal Investigator

David R Smith, PhD

PRINCIPAL INVESTIGATOR

Oregon Research Behavioral Intervention Strategies, Inc.

Frequently Asked Questions

Who can join the NCT07011940 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, studying Grief. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07011940 currently recruiting?

Yes, NCT07011940 is actively recruiting participants. Contact the research team at david.smith@influentsin.com for enrollment information.

Where is the NCT07011940 trial being conducted?

This trial is being conducted at Eugene, United States, Springfield, United States.

Who is sponsoring the NCT07011940 clinical trial?

NCT07011940 is sponsored by Oregon Research Behavioral Intervention Strategies, Inc.. The principal investigator is David R Smith, PhD at Oregon Research Behavioral Intervention Strategies, Inc.. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology